Meta has released a new AI model that combines reinforcement learning with large language models to create a more transparent and reliable insulin pump controller for Type 1 Diabetes patients. The model, called LLM-T1D, has shown promising results in blood sugar control and safety verification. This breakthrough has the potential to revolutionize the treatment of Type 1 Diabetes and improve the lives of millions of people worldwide.

A new study introduces a benchmark evaluation framework for measuring the faithfulness of LLM-generated clinical trial summaries, identifying Unsupported Claims as the dominant failure mode. The study evaluates three language models, including GPT-4o, Claude Sonnet 4.6, and Gemini 2.5 Flash, and proposes a knowledge-graph-augmented retrieval system to improve faithfulness scores. This research has significant implications for the use of LLMs in high-stakes contexts such as healthcare.

Google researchers introduce HCC-STAR, a clinical-reasoning LLM for risk stratification and treatment guidance in hepatocellular carcinoma. This model achieves state-of-the-art performance in treatment recommendation and risk stratification. The study demonstrates the potential of AI in precision therapy for HCC patients.

Researchers from Anthropic have introduced a new diagnostic to evaluate the physics literacy of large language models (LLMs) in parallel physical worlds. The study tested three LLMs, including Claude Opus 4.7, GPT-5.5, and Gemini 3.1 Pro, and found significant gaps in their ability to reason about unfamiliar physics frameworks. The results have important implications for the development and application of LLMs in scientific and technical domains.